Sustaining long-term follow-up in cell and gene therapies
IQVIA’s Diego Correa and Jip Klerks reflect on how engagement in CGT trials can be maintained with flexible, patient-centered studies.
IQVIA’s Diego Correa and Jip Klerks reflect on how engagement in CGT trials can be maintained with flexible, patient-centered studies.